IE60055B1 - Dihydropyridines - Google Patents

Dihydropyridines

Info

Publication number
IE60055B1
IE60055B1 IE128388A IE128388A IE60055B1 IE 60055 B1 IE60055 B1 IE 60055B1 IE 128388 A IE128388 A IE 128388A IE 128388 A IE128388 A IE 128388A IE 60055 B1 IE60055 B1 IE 60055B1
Authority
IE
Ireland
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
amino
Prior art date
Application number
IE128388A
Other languages
English (en)
Other versions
IE881283L (en
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of IE881283L publication Critical patent/IE881283L/xx
Publication of IE60055B1 publication Critical patent/IE60055B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
IE128388A 1987-05-02 1988-04-29 Dihydropyridines IE60055B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878710493A GB8710493D0 (en) 1987-05-02 1987-05-02 Dihydropyridines

Publications (2)

Publication Number Publication Date
IE881283L IE881283L (en) 1988-11-02
IE60055B1 true IE60055B1 (en) 1994-05-18

Family

ID=10616773

Family Applications (1)

Application Number Title Priority Date Filing Date
IE128388A IE60055B1 (en) 1987-05-02 1988-04-29 Dihydropyridines

Country Status (13)

Country Link
US (1) US4806557A (fr)
EP (1) EP0290211B1 (fr)
JP (1) JPS63297365A (fr)
AT (1) ATE66915T1 (fr)
CA (1) CA1326672C (fr)
DE (1) DE3864573D1 (fr)
DK (1) DK172094B1 (fr)
ES (1) ES2031595T3 (fr)
FI (1) FI90415C (fr)
GB (1) GB8710493D0 (fr)
GR (1) GR3002767T3 (fr)
IE (1) IE60055B1 (fr)
PT (1) PT87361B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
US6057344A (en) 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
DK1196414T3 (da) * 1999-06-25 2003-11-24 Vertex Pharma Prolægemiddel af carbamathæmmer for IMPDH
US6521647B2 (en) 2000-04-04 2003-02-18 Pfizer Inc. Treatment of renal disorders
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
BR0116553A (pt) 2000-12-29 2004-02-03 Pfizer Ltd Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão
WO2002053541A1 (fr) 2000-12-29 2002-07-11 Pfizer Limited Derive d'amide d'amlodipine
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
CA2433181C (fr) 2000-12-29 2005-11-22 Pfizer Limited Fumarate d'amlodipine
RS53403A (sr) 2000-12-29 2006-10-27 Pfizer Limited Postupak za dobijanje amlodipin maleata
CA2433284A1 (fr) 2000-12-29 2002-07-11 Pfizer Limited Standards de reference destines a la determination de la purete ou de la stabilite de maleate d'amlodipine et procedes correspondants
BR0116552A (pt) 2000-12-29 2004-02-03 Pfizer Ltd Hemi-maleato de amlodipina, processo, método para o tratamento ou prevenção de angina ou hipertensão, composição farmacêutica, para uso no tratamento e/ou de angina ou da hipertensão
US6653481B2 (en) 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
MXPA03005882A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
US6699892B2 (en) 2002-06-04 2004-03-02 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salt of amlodipine and method of preparing the same
KR100496436B1 (ko) * 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100462304B1 (ko) * 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR100538641B1 (ko) * 2002-07-30 2005-12-22 씨제이 주식회사 암로디핀의 유기산염
KR20040011751A (ko) * 2002-07-30 2004-02-11 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
KR20130061148A (ko) 2010-05-03 2013-06-10 티에스에이치 바이오팜 코포레이션 리미티드 고혈압 치료용 약학 조성물 및 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
US4447613A (en) * 1979-08-24 1984-05-08 Zoecon Corporation Pyridyl esters and thiolesters of aminoalkanoic acids
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
EP0290211B1 (fr) 1991-09-04
PT87361A (pt) 1989-05-31
DK234388D0 (da) 1988-04-28
EP0290211A1 (fr) 1988-11-09
JPH0581588B2 (fr) 1993-11-15
FI882001A0 (fi) 1988-04-28
ES2031595T3 (es) 1992-12-16
ATE66915T1 (de) 1991-09-15
PT87361B (pt) 1992-08-31
DE3864573D1 (en) 1991-10-10
GB8710493D0 (en) 1987-06-03
IE881283L (en) 1988-11-02
FI90415B (fi) 1993-10-29
FI882001A7 (fi) 1988-11-03
FI90415C (fi) 1994-02-10
DK172094B1 (da) 1997-10-20
CA1326672C (fr) 1994-02-01
US4806557A (en) 1989-02-21
JPS63297365A (ja) 1988-12-05
DK234388A (da) 1989-01-19
GR3002767T3 (en) 1993-01-25

Similar Documents

Publication Publication Date Title
EP0290211B1 (fr) Dihydropyridines
CA1253865A (fr) 1,4-dihydropyridines renfermant un groupe basique amine en 2, agents anti-ischemiques et antihypertenseurs
EP0060674B1 (fr) Agents dihydropyridiniques anti-ischemiques et antihypertensifs, leur procédé de préparation et compositions pharmaceutiques les contenant
US4952592A (en) 1,4-dihydro 2,6-dimethyl 4-(2,3-methylenedioxyphenyl) 3-alkoxy carbonyl 5-[2-(substituted amino)ethoxy]carbonyl pyridine
JPS6185362A (ja) 新規ジアリール化合物
IE832058L (en) 1,4-dihydropyridine derivatives
CZ281597B6 (cs) Enantiomery 1,4-dihydropyridinu, způsob jejich přípravy a farmaceutické prostředky z nich připravené
HUT59905A (en) Process for producing pharmaceutical compositions containing n-alkylized 1,4-dihydridine-dicarboxylic acid-esters and process for producing new n-alkylized 1,4-dihydropyridine-carboxylic acid-esters
US4618609A (en) Anti-ischaemic and antihypertensive 2-[pyrimidyloxy alhoxymethyl]-1,4-dihydropyridines
US4647565A (en) 2-(2-quinazolinylaminoalkoxymethyl)-1,4-dihydropyridine derivatives as cardiovascular agents
US4654353A (en) Antihypertensive 2-hydroxyalkoxyalkyl dihydropyridines
EP1694645B1 (fr) Gentisate d'amlodipine et procede de fabrication
US4321384A (en) Antihypertensive agents
US4795814A (en) Process for preparing novel dihydropyridine derivatives
EP0200524A2 (fr) Antagonistes de dihydropyridine calcium
US5158963A (en) 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
US4547502A (en) Dihydropyridines and their use in treating cardiac conditions and hypertension
AU592498B2 (en) Dihydropyridines
JPS6330304B2 (fr)
EP0342577B1 (fr) Utilisation des dérivés de dihydropyridine pour la prévention ou le traitement des maladies de la circulation cérébrale
NZ204283A (en) Dihydropyridine derivatives and pharmaceutical compositions
GB2050375A (en) 4-Cyanophenyl-1,4- dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
NZ207716A (en) 3-(2-furoyl)-5-alkoxy-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine derivatives and pharmaceutical compositions
JPH0155268B2 (fr)
CA1268767A (fr) Derives de substitution 1-phenylalcoyl-4- piperidinylique en n de l'ido-indole de 5- sulfamoyl-6-halogeno-3-oxo-iso-indole, diuretiques et antihypertenseurs

Legal Events

Date Code Title Description
MM4A Patent lapsed